2013-06-20 - Male
534491
| Adverse reaction report number | 534491 |
| Latest AER version number | 0 |
| Market authorization holder AER number | N/A |
| Initial received date | 2013-06-20 |
| Latest received date | 2013-06-20 |
| Age | N/A |
| Gender | Male |
| Weight | N/A |
| Type of report | Spontaneous |
| Reporter type | Physician |
| Source of report | Community |
| Report outcome | Unknown |
| Serious report? | No |
| Product description | Dosage form | Health product role | Route of administration | Dose | Frequency | Therapy duration | Indication(s) |
|---|---|---|---|---|---|---|---|
| ADDERALL XR 20MG | CAPSULE, EXTENDED RELEASE | Suspect | Oral | 20 Milligram | 1 every 1 Day(s) | Attention deficit/hyperactivity disorder | |
| CLONIDINE | NOT SPECIFIED | Concomitant | |||||
| SEROQUEL | TABLET | Concomitant | |||||
| VALPROIC ACID | NOT SPECIFIED | Concomitant |
| MedDRA version: v.21.1 | |
| Adverse reaction terms | Reaction duration |
|---|---|
| Weight decreased | |